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Abstract: In SH-SY5Y human neuroblastoma cells, insulin-like
growth factor (IGF)-l mediates membrane ruffling and growth
cone extension. We have previously shown that IGF-l activates
the tyrosine phosphorylation of focal adhesion kinase (FAK) and
extracellular signal-regulated protein kinase (ERK) 2. In the cur-
rent study, we examined which signaling pathway underlies IGF-
I-mediated FAK phosphorylation and cytoskeletal changes and
determined if an intact cytoskeleton was required for IGF-I sig-
naling. Treatment of SH-SY5Y cells with cytochalasin D dis-
rupted the actin cytoskeleton and prevented any morphological
changes induced by IGF-I. Inhibitors of phosphatidylinositol 3-
kinase (P1 3-K) blocked IGF-l-mediated changes in the actin
cytoskeleton as measured by membrane ruffling. In contrast,
P098059, a selective inhibitor of ERK kinase, had no effect on
IGF-l-induced membrane ruffling. In parallel with effects on the
actin cytoskeleton, cytochalasin D and P1 3-K inhibitors blocked
IGF-l-induced FAK tyrosine phosphorylation, whereas PD98059
had no effect. It is interesting that cytochalasin D did not block
IGF-l-induced ERK2 tyrosine phosphorylation. Therefore, it is
likely that FAK and ERK2 tyrosine phosphorylations are regulated
by separate pathways during IGF-l signaling. Our study suggests
that integrity as well as dynamic motilityof the actin cytoskeleton
mediated by P1 3-K is required for IGF-I-induced FAK tyrosirle
phosphorylation, but not for ERK2 activation. Key Words: Insu-
lin-like growth factor 1—Actin cytoskeleton—Focal adhesion ki-
nase—Extracellular signal-regulated protein kinase—Phospha-
tidylinositol 3-kinase.
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Insulin-like growth factor (IGF)-I is a polypeptide that
plays an essential role in embryonic and early postnatal de-
velopment (Zackenfels et al., 1995). In the nervous system,
IGF-I is important for cytoskeletal organization and exten-
sion of growth cones. These changes in neuronal architecture
require IGF-I-mediated redistribution of the actin cytoskele-
ton (Kadowaki et al., 1986; Leventhal et a!., 1997).
We are interested in the downstream signaling pathways
activated by IGF-I during nervous system growth. We have
reported that IGF-I binds to the type I IGF receptor and
activates the mitogen-activated protein (MAP) kinase and
phosphatidylinositol 3-kinase (P1 3-K) pathways (Kim et
al., 1997; Leventhal and Feldman, 1997; Leventhal et al.,
1997; Cheng and Feldman, 1998). Our work suggests that
the physiological effects of each pathway are separable. For
example, IGF-I activation of extracellular signal-regulated
protein kinase (ERK) 2, the most studied member of the
MAP kinase family, results in neuronal differentiation (Kim
et al., 1997), whereas IGF-I blocks neuronal apoptosis via
P1 3-K signaling (Singleton et al., 1996). We do not know
the relationship between these two pathways and the ability
of IGF-I to reorganize the actin cytoskeleton. Furthermore,
it is not known if cytoskeletal organization is a prerequisite
for one or more aspects of IGF-I-mediated signaling.
To answer these questions, we initially investigated one
downstream target of P1 3-K, focal adhesion kinase (FAK).
FAK is a cytoplasmic tyrosine kinase (Ilic et al., 1997; Za-
chary, 1997) instrumental in growth factor-mediated changes
in cytoskeletal organization (reviewed by Carpenter and Cant-
ley, 1996). IGF-I and insulin can either phosphorylate or
dephosphorylate FAK, depending on the cell type and the
adhesion status (Pillay et al., 1995; Leventhal et al., 1997;
Baron et al., 1998). We have found that IGF-I stimulates
the tyrosine phosphorylation of FAK in neurons as growth
cones advance over the substrate (Leventhal et al., 1997).
In the current study, we examined which signaling path-
wayunderlies IGF-I-mediated FAK phosphorylation andcy-
toskeletal changes and determined if an intact cytoskeleton
was required for IGF-I signaling. In our experiments, we
used SH-SY5Y human neuroblastoma cells, a well-studied
in vitro model of neuronal growth and differentiation (Feld-
man and Randolph, 1991; Lavenius et al., 1994; Leventhal
et al., 1995). We report that IGF-I-mediated FAK tyrosine
phosphorylation and changes in neuronal morphology re-
quire P1 3-K signaling. Wealso found that disruption of the
actin cytoskeleton blocks IGF-I activation of FAK but has
no effect on IGF-I activation of MAP kinase pathways.
These results are discussed in terms of a general model of
growth factor-mediated changes in neuronal architecture.
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MATERIALS AND METHODS
Materials
Anti-phosphotyrosine antibodies were purchased as fol-
lows: PY2O from Transduction Laboratories (Lexington,
KY, U.S.A.) and 4G10 from Upstate Biochemicals (Lake
Placid, NY, U.S.A.). Anti-FAK and anti-ERK2 polyclonal
antibodies were purchased from Santa Cruz Biotechnology
(SantaCruz, CA, U.S.A.). LY294002 and wortmannin were
purchased from Biomol (Plymouth Meeting, PA, U.S.A.).
Cytochalasin D was purchased from Calbiochem (San
Diego, CA, U.S.A.). PD98059 was kindly provided by Dr.
A. Saltiel of Parke-Davis Pharmaceutical Research (Ann
Arbor, MI, U.S.A.). Other reagents were purchased from
Sigma (St. Louis, MO, U.S.A.) or Boehringer-Mannheim
(Indianapolis, IN, U.S.A.).
Cell culture
SH-SY5Y human neuroblastoma cells were grown in Dul-
becco’s modified Eagle’s medium containing 10% calf se-
rum and maintained at 37°C in a humidified atmosphere
with 10% CO2. For immunocytochemistry experiments, cells
were grown on glass coverslips. At 18—24 h before experi-
ments, medium was replaced with Dulbecco’s modified Ea-
gle’s medium without serum.
Immunoprecipitation, immunoblotting, and
immunocytochemistry
Immunoprecipitation and immunoblotting were performed
as described previously (Kim et al., 1997). All experiments
were repeated at least twice, and typical representative results
are shown in the figures. Immunocytochemistry wasperformed
as described previously (Leventhal et al., 1997). SH-SY5Y
cells grownon glass coverslips were fixed in 4%paraformalde-
hyde andpermeabilizedin 0.15% Triton X-lOO plus 1% bovine
serum albumin in phosphate-buffered saline, pH 7.2. Actin
filaments were stained for 15 mm with 2 units/ml rhodamine—
phalloidin (Molecular Probes, Eugene, OR, U.S.A.).
RESULTS
We first examined the organization of the actin filaments
in SH-SY5Y cells by staining with rhodamine-labeled phal-
loidin. In control cells, we could detect a distinct organiza-
tion of actin cytoskeleton, including stress fibers and fib-
podia (Fig. 1A). Actin filaments were especially concen-
trated at the periphery of the cells. In agreement with our
previous results (Leventhal et al., 1997), treatment of IGF-
I resulted in theextension of growth cones. When these cells
were stained with rhodamine—phalloidin, there was a dense
staining of actin filaments at the leading membrane edges,
representing membrane ruffling (Fig. 1B). Cytochalasin D
treatment produced a gross disruption of the actin cytoskele-
ton with rounding up of the cells (Fig. 1C). Actin filaments
were redistributed into discrete round patches scattered ran-
domly over the cells. IGF-I treatment had no effect on these
changes. Treatment with two P1 3-K inhibitors alone,
LY294002 and wortmannin, had little effect on the actin
cytoskeleton; we did not observe differences in actin stress
fibers of cells treated with wortmannin versus LY294002
(datanot shown). Stress fibers andfilopodia were also main-
tained. However, these compounds prevented growth cone
extension and membrane ruffling after IGF-I treatment (Fig.
1D and B). In contrast, PD98059, an inhibitor of MAP ki-
nase kinase, did not block IGF-I-inducedgrowth cone exten-
FIG. 1. Effect of cytochalasin 0 and inhibitors of P1 3-K and
MAP kinase on IGF-l-mediated membrane ruffling. Serum-
starved SH-SY5Y cells were treated without (A and B) or with
1 mM cytochalasin D (C), 10 1jM LY294002 (D), 100 nM wort-
mannin (E), or 10 ~M P098059 (F) before a 5-mm incubation
with 10 nM IGF-l (B—F). Cells were fixed and stained with rhoda-
mine—phalloidin to visualize actin filaments. Arrowheads indicate
the membrane ruffling.
sion and membrane ruffling (Fig. IF) at doses up to 100
,uM (data not shown).
Next we examined the changes in tyrosine phosphorylation
of FAK and ERK2. In agreement with our previous reports
(Kim et al., 1997; Leventhal et a!., 1997), IGF-1 treatment
resulted in increased tyrosine phosphorylation of FAK and
ERK2 (Fig. 2). Treatment of cytochalasin D completely abol-
ishedIGF-I-induced FAK tyrosine phosphorylation (Fig. 2A).
In contrast, cytochalasin D had no effect on ERK2 tyrosine
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FIG. 2. Effect of cytochalasin 0 and inhibitors of P1 3-K and
MAP kinase on IGF-I-induced tyrosine phosphorylation of FAK
and ERK2. Cells were treated as in Fig. 1 and incubated with 10
nM IGF-I for 30 mm. Cell lysates were immunoprecipitated with
antibodies against FAK (A, C, and D) or ERK2 (B) and then
immunoblotted with anti-phosphotyrosmne antibodies. C, control;
I, IGF-l; CD, cytochalasin D; L, LY294002; W, wortmannin; P,
P098059; IP, immunoprecipitation.
phosphorylation (Fig. 2B). Recent reports show that P1 3-K
activity is required for platelet-derived growth factor-induced
FAK tyrosine phosphorylation (Rankin et al., 1996; Saito et
al., 1996). In agreement with these reports, IGF-I-induced
FAK tyrosine phosphorylation was blocked by treatment of
the cells with the P1 3-K inhibitors LY294002 andwortmannin
(Fig. 2C). In contrast, PD98059, whichinhibits IGF-I-induced
ERK2 activity (Kim et al., 1997), had no effect on FAK
tyrosine phosphorylation (Fig. 2D).
DISCUSSION
In the current study, we investigated which downstream
signaling pathway mediates theability ofIGF-I to reorganize
the actin cytoske!eton and produce membrane ruffling in
neurons. We found that two structurally unrelated P1 3-K
inhibitors, LY294002 andwortmannin, blocked IGF-I-medi-
ated membrane ruffling. In contrast, PD98059, which can
effectively block IGF-I activation of ERK2 (Kim et al.,
1997), had no effect on the ability of IGF-I to produce
ruffled membranes. These data indicate that IGF-I-mediated
changes in actin reorganization and the neuronal cytoskele-
ton are mediated via P1 3-K signaling. Our results agree
with reports in nonneuronal cells. In fibroblasts, membrane
ruffling is stimulated by several growth factors, including
IGF-I (Kotani et al., 1994; Wennström et al., 1994). In
nonneuronal cells, activation of P1 3-Kis necessary for mem-
brane ruffling by actingas an upstream regulator of the small
GTPase protein, Rac (Kotani et al., 1994; Nishiyama et al.,
1994; Wennstrdm et al., 1994; Hawkins et al., 1995; Parker,
1995). We are currently investigating the role of P1 3-K
activation of Rac in IGF-I-mediated changes in neuronal
architecture (Kim et al., 1996).
In this report, we also show that tyrosine phosphorylation
of FAK and ERK2 is differentially regulated by cytochalasin
D. IGF-I activation of FAK is blocked by cytochalasin D,
whereas the same treatment has no effect on IGF-I-mediated
ERK2 activation. FAK can be activated by integrin cluster-
ing, adhesion to theextracellular matrix (ECM), and growth
factor stimulation (Ilic et a!., 1997; Zachary, 1997). We
have also reported that binding of SH-SY5Y cells with lami-
nm can induce FAK tyrosine phosphorylation (Leventhal
and Feldman, 1996b; Leventhal et al., 1997). Our current
study suggests that integrity of actin filaments is critical for
FAK, but not ERK2, activation in neurons and that FAK and
ERK2 tyrosine phosphorylations are regulated by separate
pathways during IGF-I stimulation. These data imply that
first an external stimulus, provided by a growth factor, inte-
grin—ECM binding, or both, reorganizes the actin cytoskele-
ton. Cytoskeletal rearrangement activates proteins like FAK,
which form focal adhesions between thecell andECM (Lev-
enthal and Feldman, 1997). In contrast, ERK2 is directly
activated by IGF-I and does not require changes in neuronal
architecture for IGF-I-mediated activity.
Ourresults point out interestingdifferences between nonneu-
ronal and neuronal cells. In fibroblasts, IGF-I deactivates FAK
as cells attach and organize their cytoskeleton (Baron et a!.,
1998). In contrast, we find that IGF-I activatesFAK as neurons
attach and organize their cytoskeleton. Our data emphasize the
importance of an intactcytoskeleton for growth factor-mediated
FAK activation in neurons. Unlike fibroblasts, neurons must
form growth cones, which protrude into the substratum and
form the pathway for neurites. Our results suggest that activa-
tion of FAK promotes the formation of focal adhesions in the
organized neuronal actin cytoskeleton, permitting attachment
and extension of growth cones required for neurite outgrowth.
Thus, in neurons, FAK provides a unique point of convergence
among organization of the actin cytoskeleton, growth factor
signaling, and formation of focal adhesions.
The current study does not address thequestion of whether
or not integrin—ligand binding activates MAP kinases in SH-
SY5Y cells. However, ourprevious studies suggest integrin—
ECM binding does not activate this pathway (Leventhal and
Feldman, 1996a,b). In the current study, we demonstrate
that cytoskeletal disruption has no effect on growth factor-
mediated MAP kinase activation. These new results again
emphasize the differences between nonneuronal cells and
neurons. In contrast to our data in neurons, reports in fibro-
blasts suggest integrin binding with ECM activates MAP
kinases (Chen et al., 1994; Morino et al., 1995) and overex-
pressionof FAK enhances fibronectin-stimulatedERK2 acti-
vation (Schlaepfer and Hunter, 1997). Recently, however
two studies suggest the existence of independent integrin
signaling pathways in fibroblasts, one of which can activate
FAK and one of which affects MAP kinase (Seufferlein et
al., 1996; Lin et al., 1997). These ideas agree more with
our own observations that MAP kinase and FAK tyrosine
phosphorylations are regulated by separate pathways.
In the current study, the PT 3-K inhibitor LY294002
blocked IGF-I-mediated membrane ruffling. We also found
that LY294002 and wortmannin block IGF-I-induced FAK
tyrosine phosphorylation. In contrast, PD98059 had no ef-
fect. These results are in agreement with recent reports where
FAK associates with P1 3-K and P1 3-K activity is required
for platelet-derived growth factor-induced FAK tyrosine
phosphorylation (Chen and Guan, 1994a,b; Rankin et al.,
1996; Saito et a!., 1996). Collectively, our data and those
of others (Chen and Guan, 1994a,b; Rankin et al., 1996;
Saito et a!., 1996) suggest that not only integrity but also
dynamic motility of the actin cytoskeleton is required for
IGF-I-induced FAK tyrosine phosphorylation.
Our findings in neurons are also important in the context
of recent reports, including ourown (Singleton et al., 1996),
that growth factor protection against neuronal apoptosis is
mediated via P1 3-K pathways. Accumulating data show a
J. Neurochem., Vol. 71, No. 3, 1998
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strong association among apoptosis, cellular adhesion, and
the cytoskeleton. FAK is also now known to be a substrate
for caspase-3, a protease that serves as a cellular death ef-
fector (Widmann et a!., 1998). Our results in neurons that
both IGF-I-mediated FAK activation and IGF-I protection
against apoptosis require PT 3-K activation suggest an inter-
esting link between FAK activation and cellular protection.
In summary, IGF-I mediates changes in neuronal morphol-
ogy and activation of FAK via P1 3-K signaling. In contrast,
MAP kinase signaling is not required for either of these IGF-
I-mediated effects. These results suggest the dissociation of
IGF-I signaling for FAK and ERK2 tyrosine phosphorylation
and in mediating essential changes in neuronal architecture.
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